+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07038967

Study of Non-Center Involving Diabetic Macular Edema Progression After Cataract Surgery in Adults with Early Nuclear Cataract

Led by Ain Shams University · Updated on 2025-07-01

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

This research investigates the progression of non-center-involving diabetic macular edema NCIDME during the early period after cataract surgery using phacoemulsification. It focuses on diabetic patients who often develop cataracts at a younger age and have a higher risk of vision loss due to diabetic macular edema. The study aims to understand how NCIDME evolves shortly after surgery to better inform patient care. Participants with Grade I to Grade II nuclear cataract and NCIDME will be observed without receiving experimental treatments. Assessments include coloured photography, fluorescein angiography, and optical coherence tomography OCT scans, performed before surgery and then at 3 and 6 months afterward. These imaging techniques will help monitor the eyes condition and track changes in the macula and retina over time. During the study, participants vision will be evaluated using best corrected visual acuity at 6 months post-procedure as the main outcome. Secondary measurements include intraocular pressure, central macular thickness, and the frequency of fluorescein leakage, all assessed at 6 months. The study involves follow-up visits with detailed imaging and eye exams to observe the progression of diabetic eye changes after surgery, with the total participation lasting at least 6 months.

CONDITIONS

Brief Title

Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification

Research Team

H

Hatem F Abd Elfatah, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here